Ligand Pharmaceuticals Inc. (LGND) Enters into Agreement with Proximagen Neuroscience plc (PRX.L) for CXCR4 Target
9/17/2010 7:03:56 AM
More...
|
Proximagen Neuroscience plc (PRX.L) Signs Sale And Purchase Agreement For Sabcomeline
8/4/2010 11:38:47 AM
More...
|
Proximagen Neuroscience plc (PRX.L) Release: Interim Results For The Six Months Ended 31 May 2010
7/28/2010 10:37:34 AM
More...
|
Proximagen Neuroscience plc (PRX.L) Enters Into A Collaboration Agreement With The National Institutes of Health (NIH) For A Phase II Clinical Trial On Naluzotan
7/7/2010 10:16:26 AM
More...
|
Proximagen Neuroscience plc (PRX.L) Sublicenses Tonabersat Drug Rights in North America to Upsher-Smith Laboratories
4/12/2010 6:54:36 AM
More...
|
Proximagen Neuroscience plc (PRX.L): Unaudited Preliminary Results for the Year Ended 30 November 2009
3/30/2010 4:02:31 PM
More...
|
Proximagen Neuroscience plc (PRX.L) Announces Positive Efficacy Results In National Institutes of Health (NIH) Epilepsy Studies
3/11/2010 12:06:26 PM
More...
|
Proximagen Neuroscience plc (PRX.L) Recruits Senior GlaxoSmithKline (GSK) Executive As Non-Executive Director
2/1/2010 2:22:41 PM
More...
|
Proximagen Neuroscience plc (PRX.L) Strategic Update
2/1/2010 1:08:26 PM
More...
|
Proximagen Neuroscience plc (PRX.L) Signs to Acquire Cambridge Biotechnology from Biovitrum AB
10/22/2009 8:16:54 AM
More...
|
|